Sydney Oliver - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sydney Oliver

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Biorxiv : the Preprint Server for Biology|September 30, 2024

Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.

The Journal of Clinical Investigation|February 27, 2025

Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.

Nature Communications|September 20, 2022

Systematic profiling of conditional degron tag technologies for target validation studiesDaniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Biorxiv : the Preprint Server for Biology|September 30, 2024

Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.

The Journal of Clinical Investigation|February 27, 2025

Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.

Nature Communications|September 20, 2022

Systematic profiling of conditional degron tag technologies for target validation studiesDaniel P Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, et al.

Pageof 1